EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Applying a risk assessment guided evaluation for verifying comprehensive two-dimensional gas chromatography to analyse complex pharmaceuticals

Lukas Schwalb, Ole Tiemann, Uwe Käfer, Christopher Paul Rüger, Thomas Gröger, Ralf Zimmermann

Analytical and Bioanalytical Chemistry · 2024-02 · 416 (4) · 1033-1045

DOI: 10.1007/s00216-023-05093-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 21.12.2023. Verfasst von Lukas Schwalb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Joint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany. Hauptthemen laut MEDLINE: Reproducibility of Results. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG, Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reliability of analytical results is critical and indispensable when applied in regulated environments such as the pharmaceutical industry. Therefore, analytical workflows must be validated. However, validation guidelines are often designed for quantitative targeted analysis and rarely apply to qualitative untargeted approaches. In this study, we employ a risk assessment approach to identify critical parameters which might influence the qualitative results derived by online derivatisation — comprehensive two-dimensional gas chromatography coupled to a high-resolution time-of-flight mass spectrometer (GC × GC-HR-ToF–MS) for the analysis of the active pharmaceutical ingredient (API) sodium bituminosulfonate (SBS). To show the complexity and feasibility of such an approach, we focus on investigating three potential risk factors: sample preparation, vapourability, and the thermal stability of sulfonates. Through the individual evaluation of these potential risk factors due to the application of sample preparation approaches and thermal gravimetric analysis (TGA), we demonstrate the high derivatisation efficiency and repeatability of the online derivatisation method and confirm the absence of derivatisation-induced side reactions. In addition, we also show the potential thermal instability of an incompletely derivatised API. To address the limitation of these individual assessments, we applied a holistic evaluation step with negative electrospray ionisation Fourier transform ion cyclotron resonance mass spectrometry (ESI( −) FT-ICR MS) as an orthogonal technique. This confirms that most of the API is detected via the presented GC-based method. Thereby, we demonstrated the practical feasibility of the risk assessment-based approach to ensure the validity of the qualitative data for a complex untargeted method. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproducibility of ResultsMass SpectrometryChromatography, GasPharmaceutical PreparationsRisk Assessment

Stichwörter der Autor:innen

FT-ICR MSGC × GCHR-MSNon-biological complex drugsRisk assessmentSodium bituminosulfonate

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Joint Mass Spectrometry Centre (JMSC), Chair of Analytical Chemistry, University of Rostock, Rostock, Germany.
  • Joint Mass Spectrometry Centre (JMSC), Cooperation Group "Comprehensive Molecular Analytics" (CMA), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany.
  • Department Life, Light & Matter (LLM), University of Rostock, Rostock, Germany.
  • Leibniz-Institute of Tropospheric Research (TROPOS), Leipzig, Germany.
  • Joint Mass Spectrometry Centre (JMSC), Cooperation Group "Comprehensive Molecular Analytics" (CMA), Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Neuherberg, Germany. thomas.groeger@he…

Förderung

  • Ichthyol-Gesellschaft Cordes, Hermanni & Co. (GmbH & Co.) KG
  • Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)

Zitieren

APA

Schwalb, L., Tiemann, O., Käfer, U., Rüger, C. P., Gröger, T., & Zimmermann, R. (2024). Applying a risk assessment guided evaluation for verifying comprehensive two-dimensional gas chromatography to analyse complex pharmaceuticals. Analytical and Bioanalytical Chemistry, 416(4), 1033-1045. https://doi.org/10.1007/s00216-023-05093-9

Vancouver

Schwalb L, Tiemann O, Käfer U, Rüger CP, Gröger T, Zimmermann R. Applying a risk assessment guided evaluation for verifying comprehensive two-dimensional gas chromatography to analyse complex pharmaceuticals. Analytical and Bioanalytical Chemistry. 2024;416(4):1033-1045. doi:10.1007/s00216-023-05093-9

BibTeX
@article{Schwalb2024,
  author = {Schwalb, Lukas and Tiemann, Ole and Käfer, Uwe and Rüger, Christopher Paul and Gröger, Thomas and Zimmermann, Ralf},
  title = {Applying a risk assessment guided evaluation for verifying comprehensive two-dimensional gas chromatography to analyse complex pharmaceuticals},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2024},
  volume = {416},
  number = {4},
  pages = {1033--1045},
  doi = {10.1007/s00216-023-05093-9}
}
Kostenlos starten →